Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialMark R. Gilbert, Minesh P. Mehta, Kurt A. Jaeckle et al.|Journal of Clinical Oncology|2013Cited by 1.1k